A Phase II trial of COL-3 in patients with HIV related Kaposi's sarcoma.
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Incyclinide (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.